Repurposing of FDA-approved drugs against cancer - focus on metastasis.
about
Bioinformatics and Drug Discovery.NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness".Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells.Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.Framework and resource for more than 11,000 gene-transcript-protein-reaction associations in human metabolism.Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
P2860
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
@en
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
@nl
type
label
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
@en
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
@nl
prefLabel
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
@en
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
@nl
P2860
P356
P1433
P1476
Repurposing of FDA-approved drugs against cancer - focus on metastasis.
@en
P2093
Béla Ozsvári
Rebecca Lamb
P2860
P304
P356
10.18632/AGING.100941
P577
2016-04-02T00:00:00Z